Skip to main content

Cosyntropin Injection

Last Updated: November 14, 2022
Status: Current

Products Affected - Description
    • Cortrosyn lyophilized powder for injection, Amphastar, 0.25 mg, vial, 10 count, NDC 00548-5900-00
    • Cosyntropin lyophilized powder for injection, Mylan Institutional (Viatris), 0.25 mg, vial, 10 count, NDC 67457-0227-02
    • Cosyntropin lyophilized powder for injection, Sandoz, 0.25 mg, vial, 10 count, NDC 00781-3440-95
Reason for the Shortage
    • Amphastar has Cortrosyn on shortage due to increased demand.
    • Viatris did not provide a reason for the shortage.
    • Sandoz did not provide a reason for the shortage.
Available Products
    • There are no presentations available

Estimated Resupply Dates

    • Amphastar has Cortrosyn 0.25 mg vials on back order and the company cannot estimate a release date.
    • Viatris has cosyntropin 0.25 mg vials on back order and the company estimates a release date of late-March 2023.
    • Sandoz has cosyntropin 0.25 mg vials available but are prioritizing to existing customers.

Updated

Updated November 14, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created January 22, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.